Post-IPO Equity Pharmaceutical Companies

FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells.

Nuvectis Pharma is a biopharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer.

Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

BioNxt Solutions mission is to develop and commercialize next-generation pharmaceuticals.

Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

Poolbeg Pharma engages in the research and development of novel treatments for infectious diseases.

Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.

Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.

Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.

A life sciences company focused on transformational medicine.

Avicanna is a biopharmaceutical company that focuses on the development of the medical cannabis space.

Adial Pharmaceuticals develops prescription medications for addiction and related disorders.

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

CervoMed a clinical-stage firm focused on discovering therapies for brain degenerative illnesses.

Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.

Eyenovia is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.

Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies.

CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.